Sort
16,300 grants matching “fatty liver disease”
Postnatal Complications and Interventions against Halogenated Organics during Pregnancy
$197,159Kevin Joseph Pearson · University Of Kentucky · P42 · FY2023 · ES
A role for glycolipids and unconventional T cell subsets in alpha-gal allergy
$197,151Onyinye I Iweala · Univ Of North Carolina Chapel Hill · K08 · FY2024 · AI
A Human Gut-Liver Platform with Microbiome Interactions for In Vitro Toxicology
$197,126Salman R Khetani · University Of Illinois At Chicago · R21 · FY2025 · ES
Hepatocyte Metabolic Stress Response to Alcoholic Fatty Liver
$197,125Takeshi Saito · University Of Southern California · R21 · FY2025 · AA
Biological Effects and Mechanistic Actions of the Natural Disaccharide and Dietary Supplement, Trehalose.
$196,875Brian Jesse Debosch · Washington University · R21 · FY2020 · AT
Role of Beta-Catenin in the Molecular Pathogenesis of Alcoholic Steatohepatitis
$196,848Jaideep Behari · University Of Pittsburgh At Pittsburgh · K08 · FY2008 · AA
Chemoprevention of HCC related to MAFLD
$196,798Fasiha Kanwal · Baylor College Of Medicine · P01 · FY2023 · CA
Obesity and COVID-19: Role of Adipose Tissue
$196,750Tracey McLaughlin · Stanford University · R21 · FY2022 · AI
Hepatitis C Clinical Trial-Clinical Center
$196,654Gregory T Everson · University Of Colorado Denver · N01 · FY2009 · DK
AAV mediated gene knockdown of PIK3C2B as a therapeutic strategy for X-linked myotubular myopathy and fatty liver disease
$196,642Scott Q Harper · Research Inst Nationwide Children'S Hosp · R21 · FY2023 · AR
The role of obesity in biological responses to particulate matter in mice
$196,633Vsevolod Y Polotsky · Johns Hopkins University · P50 · FY2015 · ES
Training Program in Molecular Metabolism
$196,459Gokhan S Hotamisligil · Harvard University D/B/A Harvard School Of Public Health · T32 · FY2024 · DK
Effect of adiposity on hepatic and peripheral insulin resistance and hepatic steatosis in pubertal adolescents with type 1 diabetes
$196,440Michelle Van Name · Yale University · K23 · FY2018 · DK
Metabolomics Core
$196,424Gerald I Shulman · Yale University · U24 · FY2012 · DK
Development of Gap Junction Inhibition Therapy for Alcoholic Liver Disease
$196,305Suraj J Patel · Heprotech, Inc. · R43 · FY2014 · AA
The Unilateral Mosaic (UMos): Novel tools to compartmentalize pathology and trace cellular interactions in mouse models of human disease
$196,250David W Gludish · Cornell University · R21 · FY2025 · OD
PET-enabled Dual-energy CT
$196,250Guobao Wang · University Of California At Davis · R21 · FY2021 · EB
Control of protein intake and metabolism by FGF21
$196,250Karen Ryan · University Of California At Davis · R56 · FY2018 · DK
Physiological Significance of Conjugated Double Bonds in Membrane Lipids
$196,250Papasani V Subbaiah · University Of Illinois At Chicago · R21 · FY2009 · DK
PET-enabled Dual-energy CT
$196,250Guobao Wang · University Of California At Davis · R21 · FY2020 · EB
Comparative cost-effectiveness of HCC prevention in metabolic dysfunction associated fatty liver disease
$196,149Jagpreet Chhatwal · Baylor College Of Medicine · P01 · FY2023 · CA
Innovative Efficacy Measures of Lupus Nephritis Therapies
$196,087Hermine I Brunner · Cincinnati Childrens Hosp Med Ctr · U01 · FY2015 · AR
Improving Diagnosis and Prevention of Pediatric Nonalcoholic Fatty Liver Disease
$196,065Jennifer Aimee Woo Baidal · Columbia University Health Sciences · K23 · FY2018 · DK
EARLY DETECTION OF DIABETIC RETINOPATHY BY PERIPHERAL BLOOD LIPID PROFILING
$196,062Rithwick Rajagopal · Washington University · K08 · FY2019 · EY
EARLY DETECTION OF DIABETIC RETINOPATHY BY PERIPHERAL BLOOD LIPID PROFILING
$196,062Rithwick Rajagopal · Washington University · K08 · FY2017 · EY